You can buy or sell Antares Pharma and other stocks, options, ETFs, and crypto commission-free!
Antares Pharma, Inc. engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED (testosterone enanthate) injection, OTREXUP (methotrexate) injection for subcutaneous use, and Sumatriptan Injection. Read More The company was founded in February 1979 and is headquartered in Ewing, NJ.
Ewing, New Jersey
52 Week High
52 Week Low
Stock Price, News, & Analysis for Antares Pharma
Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; and Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. Its in...
Simply Wall StMar 15
Should You Worry About Antares Pharma, Inc.’s (NASDAQ:ATRS) CEO Salary Level?
Bob Apple became the CEO of Antares Pharma, Inc. (NASDAQ:ATRS) in 2016. First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will consider the growth in the business. Third, we’ll reflect on the total return to shareholders over three years, as a second measure of business performance. This process should give us an idea about how appropriately the CEO is paid. Check out our latest analysis for Antares Pharma How Does Bob Apple’s Compensation Compa...
Expected May 7, Pre-Market